Anavex Life Sciences Corp (AVXL)

[Talon38]

Bio...Thanks for the link to Biogen's CFO interview with Morgan Stanley. I agree with your high points of the interview...the company's sound financially....M/S market at $20B annually...we lead there but he used the words, flatish and resiliency = competition coming.....little enthusiasm for the Alzheimer's drugs BAN2401 and Aducnumab being codeveloped with Eaisi....need increased focus on non-US markets (good plug for out AUS and Spain trials).

The big take away IMHO was his comments on business development. Plenty of money available with Biogen's acquisition of Ionis's gene modification technology at $1B being their conservative top buy. However, the CFO hinted that Biogen would be willing to spend more on proven drugs in P3 trials and coyly dropped the AveXis $8B sale this year as an example.

I think, bolstered by this interview and the ongoing MTA, that we have been in business discussions for some months however, the sticking points have been 2-73's possible broad application beyond M/S and Alzheimer's and $'s. Think we shall see more before the end of the year.